Last $1.28 USD
Change Today +0.02 / 1.59%
Volume 2.3K
CATS On Other Exchanges
Symbol
Exchange
OTC BB
As of 9:38 AM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

catasys inc (CATS) Snapshot

Open
$1.27
Previous Close
$1.26
Day High
$1.28
Day Low
$1.27
52 Week High
07/9/12 - $2.40
52 Week Low
03/27/13 - $0.75
Market Cap
18.3M
Average Volume 10 Days
3.1K
EPS TTM
$-3.14
Shares Outstanding
14.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CATASYS INC (CATS)

Related News

No related news articles were found.

catasys inc (CATS) Related Businessweek News

No Related Businessweek News Found

catasys inc (CATS) Details

Catasys, Inc. provides specialized health management services to health plans, employers, and unions through a network of licensed and company managed health care providers. It operates in two segments, healthcare services, and license and management services. The company’s substance dependence program is designed to address substance dependence as a chronic disease. It offers OnTrak integrated substance dependence solution that combines medical and psychosocial treatments with elements of population health management and ongoing member support to treat and manage substance dependent populations. OnTrak integrated substance dependence program includes various components, including member identification and engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company also provides the PROMETA Treatment Program, an integrated, physician-based outpatient addiction treatment program that combines medical treatment, nutritional support, and psychosocial therapy to help people address addiction to alcohol and stimulants, such as cocaine and methamphetamine. In addition, it operates a licensed and managed treatment center, which offers a range of addiction treatment and mental health services. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2003 and is based in Los Angeles, California.

32 Employees
Last Reported Date: 04/1/13
Founded in 2003

catasys inc (CATS) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $450.0K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $365.3K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2012.

catasys inc (CATS) Key Developments

Catasys, Inc. Presents at 1 st Annual Singular Research Solstice Conference, Jun-13-2013 09:30 AM

Catasys, Inc. Presents at 1 st Annual Singular Research Solstice Conference, Jun-13-2013 09:30 AM. Venue: The Millennium Broadway Hotel, New York, New York, United States.

Catasys, Inc. Reports Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2013

Catasys, Inc. reported consolidated unaudited earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported total revenues of $135,000 compared with $93,000 for the same period last year. Loss from operations was $1,745,000 compared with $2,796,000 for the same period last year. Income from operations before provision for income taxes was $2,615,000 compared with loss from operations before provision for income taxes $3,380,000 for the same period last year. Net income was $2,613,000 or $0.16 diluted per share compared with net loss of $3,373,000 or $0.99 diluted per share for the same period last year. Increased revenues are a result of a 26% increase in enrollment growth (on an equal number of lives) compared with the same quarter in 2012.

Catasys, Inc. has Changed its Ticker to CATS from CATS.D

Effective May 06, 2013, Catasys, Inc. changed its OTC Bulletin Board stock ticker symbol to CATS from CATS.D.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CATS:US $1.28 USD +0.02

CATS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $29.39 USD -0.52
Brain Resource Ltd A$0.26 AUD 0.00
Bristol-Myers Squibb Co $46.85 USD 0.00
Forest Laboratories Inc $41.53 USD -0.04
Genomic Health Inc $33.29 USD -0.76
View Industry Companies
 

Industry Analysis

CATS

Industry Average

Valuation CATS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 26.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.1x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATASYS INC, please visit www.catasyshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.